首页> 外文期刊>Journal of molecular graphics & modelling >Oriented Substituent Pharmacophore PRopErtY Space(OSPPREYS): A substituent-based calculation that describes combinatorial library products better than the corresponding product-based calculation
【24h】

Oriented Substituent Pharmacophore PRopErtY Space(OSPPREYS): A substituent-based calculation that describes combinatorial library products better than the corresponding product-based calculation

机译:取向取代基药效线性能空间(OSPPREYS):基于取代基的计算,描述了组合库产品的基于基于产品的计算

获取原文
获取原文并翻译 | 示例
           

摘要

Initial combinatorial library designs were based on 2D substituent properties. Subsequently, two important extensions were introduced to improve the approach: use of pharmacophores to introduce 3D information, and performing calculations on the enumerated library products rather than just on the substituents. Unfortunately, practical compromises due to the large number of possible products, the large number of conformations per product, and the explicit dependence on the scaffold limit the application of these extensions in five important ways: (1) to small virtual libraries, (2) to only 3- or 4-point pharmacophores, (3) to inadequate conformations sampling, (4) to simplistic diversity measures, and (5) to requiring a complete new calculation for every new library. The 3D oriented substituent pharmacophores have been developed to overcome these limitations. These add two additional points and corresponding distances to each substituent pharmacophore. This adds little additional computation beyond a normal 3D pharmacophore calculation on the substituents, but recaptures most of the orienting information lost in breaking up the enumerated products into fragments. Two main approximations are still implicitly required: the combinatorial conformer assumption and the template alignment assumption. In turn, however, they are designed to account not just for the 3- and 4- point pharmacophores, but for pharmacophores with up to 9 points in enumerated products with three sites of diversity. Perhaps more importantly, pharmacophore calculations are shown to be very sensitive to conformational sampling. The small number of substituents, plus the small number of rotatable bonds per substituent, permits very thorough conformational sampling. For a rigid scaffold with three diversity sites of 1, 000 candidate substituents each, the number of molecules to analyze is reduced by a factor of 10~6, and the number of conformations per molecule is reduced by another 10~4. In addition, the modest number of pairwise substituent similarities permits the creation of a Euclidean property space by MDS. This allows for sophisticated experimental design methods that require coordinates, rather than just the counting of the number of set bits in a library union fingerprint. Finally, oriented substituent calculations are scaffold independent and transferable. They can be stored in a database and need not be repeated for every new library. Thus, there are some approximations in the correspondence between oriented substituent pharmacophore similarities and enumerated product pharmacophore similarities. However, these errors are minor compared to the five advantages that the new method enables: large virtual library sizes, thorough conformational sampling, accounting for 1- to 9-point pharmacophores, creation of a Euclidean property space, and a reusable database of precomputed substituent values.
机译:初始组合库设计基于2D取代基特性。随后,引入了两个重要的延伸以改善方法:使用药物团引入3D信息,并对枚举的库产品进行计算,而不是在取代基上进行计算。不幸的是,由于大量可能的产品,每种产品的大量构象,以及对脚手架的明确依赖性的实际妥协限制了这些扩展的应用,以五种重要的方式:(1)到小虚拟图书馆,(2)仅为3分或4点药仔,(3)对符合符合性采样的不足,(4)以简单化的多样性措施,以及(5)为每个新图书馆进行全新计算。已经开发了3D取向的取代基药长以克服这些限制。这些添加两个额外点和对应的距离到每个取代基药程孔。这增加了超出了常规3D药物团计算的额外计算,但在取代基的正常情况下,恢复大部分定向信息损失在将枚举的产品分解成碎片中。仍然隐含两个主要近似值:组合符合子假设和模板对齐假设。然而,又设计用于不仅适用于3分和4点药理,而且旨在为药委员会的药物,其中包含三个多样性的列出产品中最多9分。也许更重要的是,Pharmacophore计算被证明对构象采样非常敏感。少量取代基加上每个取代基的少量可旋转键,允许非常彻底的构象取样。对于具有1,000个候选取代基的三个分集位点的刚性支架,每种分析的分子数量减少了10〜6的因子,每分子的构象数减少了另外10〜4。此外,对成对取代的相似度的适度数量允许通过MDS创建欧几里德属性空间。这允许需要坐标的复杂的实验设计方法,而不是仅计算图书馆联合指纹中的设置位数。最后,取向的取代基计算是独立和可转移的支架。它们可以存储在数据库中,不需要为每个新库重复。因此,取向取代基药长相似性和枚举产物药仔的相似性的对应关系存在一些近似。然而,与新方法启用的五个优势相比,这些误差很小,即新方法启用:大型虚拟库尺寸,彻底构象采样,占1至9点药理的核算,创建欧几里德的属性空间,以及预先抵押的取代基数据库价值观。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号